Nihon Kohden Corporation (OTCMKTS:NHNKY) Short Interest Update

Nihon Kohden Corporation (OTCMKTS:NHNKY) was the target of a large increase in short interest in August. As of August 31st, there was short interest totaling 8,040 shares, an increase of 264.6% from the August 15th total of 2,205 shares. Approximately 0.0% of the shares of the stock are short sold. Based on an average trading volume of 13,403 shares, the days-to-cover ratio is presently 0.6 days.

Analyst Upgrades and Downgrades

Separately, UBS Group lowered Nihon Kohden from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, August 12th. Two equities research analysts have rated the stock with a Hold rating, According to MarketBeat.com, Nihon Kohden currently has a consensus rating of “Hold”.

Nihon Kohden Trading Up 4.7%

OTCMKTS NHNKY traded up $0.45 during trading on Friday, reaching $10.01. 18,352 shares of the company’s stock were exchanged, compared to its average volume of 9,907. The company’s fifty day simple moving average is $9.51 and its 200-day simple moving average is $9.41. The firm has a market capitalization of $1.68 billion, a PE ratio of 18.20 and a beta of 0.36. Nihon Kohden has a fifty-two week low of $8.12 and a fifty-two week high of $14.21.

Nihon Kohden (OTCMKTS:NHNKY) last announced its quarterly earnings data on Thursday, August 6th. The company reported ($0.03) EPS for the quarter, missing analysts’ consensus estimates of $0.06 by ($0.09). The company had revenue of $297.47 million for the quarter, compared to analysts’ expectations of $299.98 million. Nihon Kohden had a net margin of 5.90% and a return on equity of 9.08%. Equities analysts forecast that Nihon Kohden will post 0.6 EPS for the current fiscal year.

Nihon Kohden Company Profile

Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan’s earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.

The company’s core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.